Search - tctmd.com

Displaying 961 - 980 of 2724

Sort: Relevancy | Date

News Daily News

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

Nicole Lou

June 16, 2015

News Daily News

TOTAL Substudy: Routine Thrombectomy Has No Effect on Culprit Lesion Thrombus Burden in STEMI

L.A. McKeown

June 15, 2015

News Daily News

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Caitlin E. Cox

June 15, 2015

News Daily News

LV Flow After TAVR Predicts Late Mortality

June 11, 2015

News Daily News

Meta-analysis Supports Benefit of Complete Revascularization in STEMI

Todd Neale

June 11, 2015

News Daily News

Meta-analysis Confirms Late Safety of Second-Generation DES

L.A. McKeown

June 10, 2015

News Daily News

Event Rates Often Overestimated in Cardiovascular Trials

Yael L. Maxwell

June 10, 2015

News Industry News

First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit

June 09, 2015

News Daily News

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

June 09, 2015

News Daily News

Washington State Sees Increase in Appropriate PCI After AUC Introduction

L.A. McKeown

June 08, 2015

News Daily News

Stenting Provides Better Early Outcomes vs Angioplasty Alone for PAD

Todd Neale

June 08, 2015

Presentation TVT 2015

New Indications Coming: The Role of the Heart Team in the Assessment of Intermediate- and Low-Risk Patients

Presenter: Susheel K. Kodali, David A. Wood

June 06, 2015

News Industry News

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

June 05, 2015

News Industry News

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

June 05, 2015

News Daily News

Advantage of Radial PCI Most Apparent at Extremes of BMI

Caitlin E. Cox

June 05, 2015

News Daily News

IMPROVE-IT Published: Hotly Debated Ezetimibe Helpful When Added to Statin Therapy

Yael L. Maxwell

June 05, 2015

Presentation TVT 2015

A Surgeons Perspective: Will the IMPLANTING TEAM Change for Intermediate- and Low-Risk Transfemoral TAVR Patients?

Presenter: Francesco Maisano

June 04, 2015

Presentation TVT 2015

Should the Minimalist Approach Change for Intermediate- and Low-Risk TAVR Patients?

Presenter: Vinayak Bapat

June 04, 2015

Presentation TVT 2015

Making the Case for TAVR Expansion to Lower-Risk Patients!

Presenter: Robert O. Bonow, Martin B. Leon, Jean-Michel Paradis, Nicolo Piazza

June 04, 2015

News Daily News

替卡格雷预治疗有助于预防 NSTE-ACS 围手术期心肌坏死

June 04, 2015

Advertisement

With Newer-Generation DES, Ultralong Stenting Tied to Adverse Events

TOTAL Substudy: Routine Thrombectomy Has No Effect on Culprit Lesion Thrombus Burden in STEMI

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

LV Flow After TAVR Predicts Late Mortality

Meta-analysis Supports Benefit of Complete Revascularization in STEMI

Meta-analysis Confirms Late Safety of Second-Generation DES

Event Rates Often Overestimated in Cardiovascular Trials

First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

Washington State Sees Increase in Appropriate PCI After AUC Introduction

Stenting Provides Better Early Outcomes vs Angioplasty Alone for PAD

New Indications Coming: The Role of the Heart Team in the Assessment of Intermediate- and Low-Risk Patients

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

Advantage of Radial PCI Most Apparent at Extremes of BMI

IMPROVE-IT Published: Hotly Debated Ezetimibe Helpful When Added to Statin Therapy

A Surgeons Perspective: Will the IMPLANTING TEAM Change for Intermediate- and Low-Risk Transfemoral TAVR Patients?

Should the Minimalist Approach Change for Intermediate- and Low-Risk TAVR Patients?

Making the Case for TAVR Expansion to Lower-Risk Patients!

替卡格雷预治疗有助于预防 NSTE-ACS 围手术期心肌坏死

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content